Multi-epitope T-cell Vaccine Shows Promise in Ovarian, Breast CancerByBy John SchieszerMay 16th 2018TPIV200 stimulates T cells to attack ovarian and triple-negative breast tumor cells that over-express the folate receptor alpha protein.